Paclitaxel and Platinum Chemotherapy for Malignant Mixed Mullerian Tumors of the Ovary
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (3), 459-463
- https://doi.org/10.1006/gyno.2002.6645
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chemotherapy for Malignant Mixed Müllerian Tumors of the OvaryGynecologic Oncology, 2000
- Malignant mixed mesodermal tumors of the ovaryPublished by Wolters Kluwer Health ,2000
- Malignant Mixed Mesodermal Ovarian Tumor Treatment and Prognosis: A 20-Year ExperienceGynecologic Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Malignant mixed müllerian tumors of the ovary. Experience with surgical cytoreduction and combination chemotherapyCancer, 1995
- A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1994
- Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyGynecologic Oncology, 1990
- Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovaryGynecologic Oncology, 1989
- A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group studyGynecologic Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981